USD 1.75 billion
Report ID:
SQMIG35H2039 |
Region:
Global |
Published Date: November, 2024
Pages:
165
|Tables:
66
|Figures:
75
Global Recombinant Proteins Market size was valued at around USD 2.20 billion in 2022 and is expected to rise from USD 2.36 billion in 2023 to reach a value of USD 4.11 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).
The global recombinant protein market size is projected to rise at a high CAGR between 2023 and 2030. The genetic level of recombinant proteins proceeds with the isolation of coding sequence for the target protein and its cloning into an expression plasmid vector. The majority of therapeutic recombinant proteins are produced in microbes, yeast, or animal cells in culture. Studying protein-protein interactions requires the use of recombinant proteins. Detergents, beauty products, food supplements, food manufacturing, diagnostics, vaccinations, and therapies are just a few of the applications for these proteins.
Rise in the healthcare organizations investment in research and development activities, growing frequency of chronic illnesses, and a spike in the range of regulatory bodies ought to reduce viral infections are the primary factors towards the growth of the global recombinant protein market.
Global Market Size
USD 1.75 billion
Largest Segment
Hormones
Fastest Growth
hormone
Growth Rate
12% CAGR
To get more reports on the above market click here to Buy The Report
Global Recombinant Proteins Market is segmented by Product, Application, Host cell, End User and region. Based on Product, the market is segmented into Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Proteins, Hormones, Others. Based on Application, the market is segmented into Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Biopharmaceutical Production, Research (Academic Research, Biotechnology Research), Diagnostics, and Others. Based on Host cell, the market is segmented into Mammalian Systems, Insect Cells, Yeast & Fungi, Bacterial Cells, and Others. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical, Academic Research Institutes, Contract Research Organizations, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Product Type
In 2022, among the following segment growth factors and enzymes segment due to its use in a variety of research domains accounted for the highest overall market share and is expected to expand at the highest rate during the forecast period. Chemotaxis, neurology, wound repair, immunotherapy, transplantation, apoptosis, oncology, aids, COVID-19, cell culture, and stem cell research are responsible for a substantial component of the growth factors and enzymes industry.
Analysis by Application
In terms of revenue, therapeutic accounted for a significant share in 2022 and it is expected to grow during the forecast period. Products containing recombinant proteins are used to treat various ailments like hyperglycemia, lymphoma, and inflammatory disorders. The segment is expected to maintain its dominance throughout the forecast period owing to the need for innovative therapeutic approach which is projected to rise as the incidence of diseases is growing.
To get detailed analysis on other segments, Request For Free Sample Report
In 2022, North America accounted for the largest share of the global market, and this trend is expected to continue during the forecast. The rising prevalence of chronic diseases, growing R&D investments, increased research and government incentives, and the presence of manufacturing companies in the U.S. are all factors contributing to North America’s market development.
Due to an increase in purchasing power of Asian countries, as well as research and investment, it has a significant market opportunity for further development. Numerous government policies in various nations have exerted an influence on the market in the forecast period.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Driver
Increasing demand for Biopharmaceuticals and R&D investment to fuel the recombinant protein market.
Restraint
Decreasing cost of recombinant protein and lack of professionals to limit the market growth.
Request Free Customization of this report to help us to meet your business objectives.
There are several dominant players in the recombinant protein business. Several strategic activities, such as mergers, partnerships, alliances, new product launches, acquisitions, and collaborations, are being implemented by the firms to help them increase their international competitiveness. For instance, in February 2021, In order to determine the best antigen dosages for the Phase 3 evaluation of its adjuvanted recombinant protein COVID-19 vaccine candidates, Sanofi and GSK have begun a new Phase 2b trial with 720 individuals who are 18 years old & older.
Recombinant Protein Market Top Players Company Profiles
Recombinant Protein Market Recent Development
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to the global recombinant protein market report analysis, the growth factors and Enzymes market has the largest revenue share in 2022. The Therapeutics application has dominated the market with a market share for 2022. Region-wise, the North American region accounted for the highest market share in 2022.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 2.20 billion |
Market size value in 2031 | USD 4.11 billion |
Growth Rate | 7.2% |
Base year | 2023 |
Forecast period | 2024–2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Recombinant Protein Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Recombinant Protein Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Recombinant Protein Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Recombinant Protein Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2039
sales@skyquestt.com
USA +1 351-333-4748